Novel strategies for the early detection and prevention of lung cancer

Seminars in Oncology

Volumn 32, Issue 3 SOPEC. ISS, 2005, Pages 259-268

  Wardwell Jr , Noel R ^b   Massion, Pierre P ^a  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GEFITINIB; ILOPROST; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE INHIBITOR; RETINOID;

BRONCHOSCOPY; CANCER DIAGNOSIS; CANCER GENETICS; CANCER PREVENTION; CANCER SCREENING; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CHEMOPROPHYLAXIS; COMPUTER ASSISTED TOMOGRAPHY; DNA DETERMINATION; EARLY DIAGNOSIS; EPIGENETICS; FLUORESCENCE BRONCHOSCOPY; GENOMIC INSTABILITY; HIGH RISK POPULATION; HUMAN; LUNG CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SPIRAL COMPUTER ASSISTED TOMOGRAPHY;

EID: 20644459456     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.seminoncol.2005.02.009     Document Type: Article

References (123)

1. A. Jemal, E. Ward, T. Murray Cancer statistics, 2005 CA Cancer J Clin 55 2005 10 30
2. H.K. Weir, M.J. Thun, B.F. Hankey Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control J Natl Cancer Inst 95 2003 1276 1299
3. B.K. Edwards, H.L. Howe, L.A. Ries Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden Cancer 94 2002 2766 2792
4. C.F. Mountain Revisions in the International System for Staging Lung Cancer Chest 111 1997 1710 1717
5. National Cancer Institute: Surveillance Epidemiology and End Results Program (Online). http://seer.cancer.gov, 2002
6. L.L. Humphrey, S. Teutsch, M. Johnson Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography An update for the U.S. Preventive Services Task Force Ann Intern Med 140 2004 740 753
7. B.J. Flehinger, M. Kimmel, M.R. Melamed The effect of surgical treatment on survival from early lung cancer. Implications for screening Chest 101 1992 1013 1018
8. C.K. Chan, C.K. Wells, M.J. McFarlane More lung cancer but better survival. Implications of secular trends in "necropsy surprise" rates Chest 96 1989 291 296
9. S. Sone, S. Takashima, F. Li Mass screening for lung cancer with mobile spiral computed tomography scanner Lancet 351 1998 1242 1245
10. National Cancer Institute: National Lung Screening Trial. http://www.cancer.gov/nlst, 2003
11. C. Deschamps, P.C. Pairolero, V.F. Trastek Multiple primary lung cancers. Results of surgical treatment J Thorac Cardiovasc Surg 99 1990 769 777
12. P.C. Pairolero, D.E. Williams, E.J. Bergstralh Postsurgical stage I bronchogenic carcinoma Morbid implications of recurrent disease Ann Thorac Surg 38 1984 331 338
13. M. Ribet, P. Dambron Multiple primary lung cancers Eur J Cardiothorac Surg 9 1995 231 236
14. J. Van Meerbeeck, J. Weyler, A. Thibaut Second primary lung cancer in Flanders Frequency, clinical presentation, treatment and prognosis Lung Cancer 15 1996 281 295
15. R. Peto, S. Darby, H. Deo Smoking, smoking cessation, and lung cancer in the UK since 1950 Combination of national statistics with two case-control studies BMJ 321 2000 323 329
16. M.S. Tockman, P.K. Gupta, J.D. Myers Sensitive and specific monoclonal antibody recognition of human lung cancer antigen on preserved sputum cells A new approach to early lung cancer detection J Clin Oncol 6 1988 1685 1693
17. S.A. Prindiville, T. Byers, F.R. Hirsch Sputum cytological atypia as a predictor of incident lung cancer in a cohort of heavy smokers with airflow obstruction Cancer Epidemiol Biomarkers Prev 12 2003 987 993
18. X. Wu, H. Zhao, R. Suk Genetic susceptibility to tobacco-related cancer Oncogene 23 2004 6500 6523
19. C.I. Amos, W. Xu, M.R. Spitz Is there a genetic basis for lung cancer susceptibility? Recent Results Cancer Res 151 1999 3 12
20. D. Carmelli, G.E. Swan, D. Robinette Genetic influence on smoking-A study of male twins N Engl J Med 327 1992 829 833
21. T. Arinami, H. Ishiguro, E.S. Onaivi Polymorphisms in genes involved in neurotransmission in relation to smoking Eur J Pharmacol 410 2000 215 226
22. J.E. Bailey-Wilson, C.I. Amos, S.M. Pinney A major lung cancer susceptibility locus maps to chromosome 6q2325 Am J Hum Genet 75 2004 460 474
23. G.Z. Brett The value of lung cancer detection by six-monthly chest radiographs Thorax 23 1968 414 420
24. G.Z. Brett Earlier diagnosis and survival in lung cancer Br Med J 4 1969 260 262
25. R.S. Fontana, D.R. Sanderson, W.F. Taylor Early lung cancer detection Results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study Am Rev Respir Dis 130 1984 561 565
26. A. Kubik, J. Polak Lung cancer detection. Results of a randomized prospective study in Czechoslovakia Cancer 57 1986 2427 2437
27. N.I. Berlin Overview of the NCI Cooperative Early Lung Cancer Detection Program Cancer 89 2000 2349 2351
28. M.T. Truong, R.F. Munden Lung cancer screening Curr Oncol Rep 5 2003 309 312
29. P.B. Bach, M.J. Kelley, R.C. Tate Screening for lung cancer A review of the current literature Chest 123 suppl 1 2003 72S 82S
30. J.L. Mulshine, F. Cuttitta, M.S. Tockman Lung cancer evolution to preinvasive management Clin Chest Med 23 2002 37 48
31. S.J. Swensen, J.R. Jett, T.E. Hartman Lung cancer screening with CT Mayo Clinic experience Radiology 226 2003 756 761
32. C.I. Henschke, D.P. Naidich, D.F. Yankelevitz Early lung cancer action project Initial findings on repeat screenings Cancer 92 2001 153 159
33. M. Mori, S.K. Rao, H.H. Popper Atypical adenomatous hyperplasia of the lung A probable forerunner in the development of adenocarcinoma of the lung Mod Pathol 14 2001 72 84
34. K.M. Kerr Pulmonary preinvasive neoplasia J Clin Pathol 54 2001 257 271
35. M. Nagao, K. Murase, Y. Yasuhara Measurement of localized ground-glass attenuation on thin-section computed tomography images Correlation with the progression of bronchioloalveolar carcinoma of the lung Invest Radiol 37 2002 692 697
36. M. Nakata, H. Saeki, I. Takata Focal ground-glass opacity detected by low- dose helical CT Chest 121 2002 1464 1467
37. S.J. Swensen, J.R. Jett, J.A. Sloan Screening for lung cancer with low-dose spiral computed tomography Am J Respir Crit Care Med 165 2002 508 513
38. T. Sobue, N. Moriyama, M. Kaneko Screening for lung cancer with low-dose helical computed tomography anti-lung cancer association project J Clin Oncol 20 2002 911 920
39. S. Sone, F. Li, Z.G. Yang Results of three-year mass screening programme for lung cancer using mobile low-dose spiral computed tomography scanner Br J Cancer 84 2001 25 32
40. V.J. Lowe, J.W. Fletcher, L. Gobar Prospective investigation of positron emission tomography in lung nodules J Clin Oncol 16 1998 1075 1084
41. G.J. Herder, P. Verboom, E.F. Smit Practice, efficacy and cost of staging suspected non-small cell lung cancer A retrospective study in two Dutch hospitals Thorax 57 2002 11 14
42. Canadian Lung Oncology Group Investigation for mediastinal disease in patients with apparently operable lung cancer Ann Thorac Surg 60 1995 1382 1389
43. D. Lardinois, W. Weder, T.F. Hany Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography N Engl J Med 348 2003 2500 2507
44. U. Pastorino, M. Bellomi, C. Landoni Early lung-cancer detection with spiral CT and positron emission tomography in heavy smokers 2-year results Lancet 362 2003 593 597
45. S. Lam, T. Kennedy, M. Unger Localization of bronchial intraepithelial neoplastic lesions by fluorescence bronchoscopy Chest 113 1998 696 702
46. F.R. Hirsch, S.A. Prindiville, Y.E. Miller Fluorescence versus white- light bronchoscopy for detection of preneoplastic lesions a randomized study J Natl Cancer Inst 93 2001 1385 1391
47. Y. Kusunoki, F. Imamura, H. Uda Early detection of lung cancer with laser-induced fluorescence endoscopy and spectrofluorometry Chest 118 2000 1776 1782
48. M. Sato, A. Sakurada, M. Sagawa Diagnostic results before and after introduction of autofluorescence bronchoscopy in patients suspected of having lung cancer detected by sputum cytology in lung cancer mass screening Lung Cancer 32 2001 247 253
49. F.E. Carroll Tunable monochromatic x rays A new paradigm in medicine AJR Am J Roentgenol 179 2002 583 590
50. E.A. Schellenberger, A. Bogdanov Jr, D. Hogemann Annexin V-CLIO A nanoparticle for detecting apoptosis by MRI Mol Imaging 1 2002 102 107
51. E.A. Schellenberger, A. Bogdanov Jr, A. Petrovsky Optical imaging of apoptosis as a biomarker of tumor response to chemotherapy Neoplasia 5 2003 187 192
52. R.G. Blasberg, J. Gelovani Molecular-genetic imaging A nuclear medicine-based perspective Mol Imaging 1 2002 280 300
53. Z. Huang, A. McWilliams, H. Lui Near-infrared Raman spectroscopy for optical diagnosis of lung cancer Int J Cancer 107 2003 1047 1052
54. J. Welzel Optical coherence tomography in dermatology A review Skin Res Technol 7 2001 1 9
55. A. Kanamori, M. Nakamura, M.F. Escano Evaluation of the glaucomatous damage on retinal nerve fiber layer thickness measured by optical coherence tomography Am J Ophthalmol 135 2003 513 520
56. J.J. Sung Changing role of endoscopy in the new millennium. Bushell Lecture, Asia-Pacific Digestive Week 2001 J Gastroenterol Hepatol 17 2002 369 373
57. K. Yanagisawa, Y. Shyr, B.J. Xu Proteomic patterns of tumour subsets in non-small-cell lung cancer Lancet 362 2003 433 439
58. Y. Satoh, Y. Ishikawa, K. Nakagawa A follow-up study of progression from dysplasia to squamous cell carcinoma with immunohistochemical examination of p53 protein overexpression in the bronchi of ex-chromate workers Br J Cancer 75 1997 678 683
59. K.L. Braithwaite, P.H. Rabbitts Multi-step evolution of lung cancer Semin Cancer Biol 9 1999 255 265
60. Y. Ishikawa, K. Nakagawa, Y. Satoh Characteristics of chromate workers' cancers, chromium lung deposition and precancerous bronchial lesions An autopsy study Br J Cancer 70 1994 160 166
61. O. Auerbach, A.P. Stout, E.C. Hammond Changes in bronchial epithelum in reation to cigraette smoking and in relation to lung cancer N Engl J Med 265 1961 253 267
62. M.R. Emmert-Buck, R.F. Bonner, P.D. Smith Laser capture microdissection Science 274 1996 998 1001
63. D. Hanahan, R.A. Weinberg The hallmarks of cancer Cell 100 2000 57 70
64. S.A. Belinsky, K.J. Nikula, S.B. Baylin Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer Proc Natl Acad Sci U S A 93 1996 4045 4050
65. E. Brambilla, S. Gazzeri, S. Lantuejoul p53 mutant immunophenotype and deregulation of p53 transcription pathway (Bcl2, Bax, and Waf1) in precursor bronchial lesions of lung cancer Clin Cancer Res 4 1998 1609 1618
66. L. Thiberville, P. Payne, J. Vielkinds Evidence of cumulative gene losses with progression of premalignant epithelial lesions to carcinoma of the bronchus Cancer Res 55 1995 5133 5139
67. J.P. Lavieille, S. Gazzeri, C. Riva p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck Anticancer Res 18 1998 4741 4749
68. M. Jeanmart, S. Lantuejoul, F. Fievet Value of immunohistochemical markers in preinvasive bronchial lesions in risk assessment of lung cancer Clin Cancer Res 9 2003 2195 2203
69. P.P. Massion, P.M. Taflan, S.M. Jamshedur Rahman Significance of p63 amplification and overexpression in lung cancer development and prognosis Cancer Res 63 2003 7113 7121
70. R.J. Slebos, I.O. Baas, M.J. Clement p53 alterations in atypical alveolar hyperplasia of the human lung Hum Pathol 29 1998 801 808
71. Y. Aoyagi, T. Yokose, Y. Minami Accumulation of losses of heterozygosity and multistep carcinogenesis in pulmonary adenocarcinoma Cancer Res 61 2001 7950 7954
72. I.I. Wistuba, C. Behrens, A.K. Virmani High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints Cancer Res 60 2000 1949 1960
73. I.I. Wistuba, C. Behrens, S. Milchgrub Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma Oncogene 18 1999 643 650
74. Y. Kishimoto, K. Sugio, J.Y. Hung Allele-specific loss in chromosome 9p loci in preneoplastic lesions accompanying non-small-cell lung cancers J Natl Cancer Inst 87 1995 1224 1229
75. P.P. Massion, W.L. Kuo, D. Stokoe Genomic copy number analysis of non-small cell lung cancer using array comparative genomic hybridization Implications of the phosphatidylinositol 3-kinase pathway Cancer Res 62 2002 3636 3640
76. P.P. Massion, P.M. Taflan, Y. Shyr Early Involvement of the phosphatidylinositol 3-kinase/Akt pathway in lung cancer progression Am J Respir Crit Care Med 170 2004 1088 1094
77. T. Liloglou, P. Maloney, G. Xinarianos Cancer-specific genomic instability in bronchial lavage A molecular tool for lung cancer detection Cancer Res 61 2001 1624 1628
78. G. Cuda, A. Gallelli, A. Nistico Detection of microsatellite instability and loss of heterozygosity in serum DNA of small and non-small cell lung cancer patients A tool for early diagnosis? Lung Cancer 30 2000 211 214
79. M. Esteller, M. Sanchez-Cespedes, R. Rosell Detection of aberrant promoter hypermethylation of tumor suppressor genes in serum DNA from non-small cell lung cancer patients Cancer Res 59 1999 67 70
80. X.Q. Chen, M. Stroun, J.L. Magnenat Microsatellite alterations in plasma DNA of small cell lung cancer patients Nat Med 2 1996 1033 1035
81. G. Sozzi, K. Musso, C. Ratcliffe Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients A prospect for early diagnosis Clin Cancer Res 5 1999 2689 2692
82. G. Sozzi, D. Conte, M. Leon Quantification of free circulating DNA as a diagnostic marker in lung cancer J Clin Oncol 21 2003 3902 3908
83. R.D. Petty, M.C. Nicolson, K.M. Kerr Gene expression profiling in non-small cell lung cancer From molecular mechanisms to clinical application Clin Cancer Res 10 2004 3237 3248
84. D.G. Beer, S.L. Kardia, C.C. Huang Gene-expression profiles predict survival of patients with lung adenocarcinoma Nat Med 8 2002 816 824
85. J.J. Chen, K. Peck, T.M. Hong Global analysis of gene expression in invasion by a lung cancer model Cancer Res 61 2001 5223 5230
86. N. Yamagata, Y. Shyr, K. Yanagisawa A training-testing approach to the molecular classification of resected non-small cell lung cancer Clin Cancer Res 9 2003 4695 4704
87. N. Yanagawa, G. Tamura, H. Oizumi Promoter hypermethylation of tumor suppressor and tumor-related genes in non-small cell lung cancers Cancer Sci 94 2003 589 592
88. S.A. Ahrendt, J.T. Chow, L.H. Xu Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer J Natl Cancer Inst 91 1999 332 339
89. H. Usadel, J. Brabender, K.D. Danenberg Quantitative adenomatous polyposis coli promoter methylation analysis in tumor tissue, serum, and plasma DNA of patients with lung cancer Cancer Res 62 2002 371 375
90. J. Brabender, H. Usadel, R. Metzger Quantitative O(6)-methylguanine DNA methyltransferase methylation analysis in curatively resected non-small cell lung cancer Associations with clinical outcome Clin Cancer Res 9 2003 223 227
91. M. Fleischhacker, T. Beinert, M. Ermitsch Detection of amplifiable messenger RNA in the serum of patients with lung cancer Ann N Y Acad Sci 945 2001 179 188
92. P. Fielding, L. Turnbull, W. Prime Heterogeneous nuclear ribonucleoprotein A2/B1 up-regulation in bronchial lavage specimens A clinical marker of early lung cancer detection Clin Cancer Res 5 1999 4048 4052
93. S.M. Dubinett, S. Sharma, M. Huang Cyclooxygenase-2 in lung cancer Prog Exp Tumor Res 37 2003 138 162
94. Y. Hosomi, T. Yokose, Y. Hirose Increased cyclooxygenase 2 (COX-2) expression occurs frequently in precursor lesions of human adenocarcinoma of the lung Lung Cancer 30 2000 73 81
95. S. Hasturk, B. Kemp, S.K. Kalapurakal Expression of cyclooxygenase-1 and cyclooxygenase-2 in bronchial epithelium and nonsmall cell lung carcinoma Cancer 94 2002 1023 1031
96. F.R. Hirsch, M. Varella-Garcia, P.A. Bunn Jr Epidermal growth factor receptor in non-small-cell lung carcinomas Correlation between gene copy number and protein expression and impact on prognosis J Clin Oncol 21 2003 3798 3807
97. A.A. Adjei An overview of farnesyltransferase inhibitors and their role in lung cancer therapy Lung Cancer 41 suppl 1 2003 S55 S62
98. P. Chaurand, M. Stoeckli, R.M. Caprioli Direct profiling of proteins in biological tissue sections by MALDI mass spectrometry Anal Chem 71 1999 5263 5270
99. G. Chen, T.G. Gharib, H. Wang Protein profiles associated with survival in lung adenocarcinoma Proc Natl Acad Sci U S A 100 2003 13537 13542
100. D. Sidransky, R. Irizarry, J.A. Califano Serum protein MALDI profiling to distinguish upper aerodigestive tract cancer patients from control subjects J Natl Cancer Inst 95 2003 1711 1717
101. B.A. Howard, M.Z. Wang, M.J. Campa Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization-time of flight spectra analysis Proteomics 3 2003 1720 1724
102. M. Sullivan Pepe, R. Etzioni, Z. Feng Phases of biomarker development for early detection of cancer J Natl Cancer Inst 93 2001 1054 1061
103. J. Kononen, L. Bubendorf, A. Kallioniemi Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 4 1998 844 847
104. W.K. Hong, S.M. Lippman, L.M. Itri Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck N Engl J Med 323 1990 795 801
105. U. Pastorino, M. Infante, M. Maioli Adjuvant treatment of stage I lung cancer with high-dose vitamin A J Clin Oncol 11 1993 1216 1222
106. G.S. Omenn, G. Goodman, M. Thornquist The beta-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations Smokers and asbestos-exposed workers Cancer Res 54 suppl 7 1994 2038s 2043s
107. F. Furukawa, A. Nishikawa, I.S. Lee A cyclooxygenase-2 inhibitor, nimesulide, inhibits postinitiation phase of N-nitrosobis(2-oxopropyl)amine- induced pancreatic carcinogenesis in hamsters Int J Cancer 104 2003 269 273
108. C. Gridelli, P. Maione, G. Airoma Selective cyclooxygenase-2 inhibitors and non-small cell lung cancer Curr Med Chem 9 2002 1851 1858
109. R.E. Harris, J. Beebe-Donk, H.M. Schuller Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers Oncol Rep 9 2002 693 695
110. C.L. Arteaga, D.H. Johnson Tyrosine kinase inhibitors-ZD1839 (Iressa) Curr Opin Oncol 13 2001 491 498
111. S. Subongkot, D. Frame, W. Leslie Selective cyclooxygenase-2 inhibition A target in cancer prevention and treatment Pharmacotherapy 23 2003 9 28
112. D.H. Johnson Gefitinib (Iressa) trials in non-small cell lung cancer Lung Cancer 41 suppl 1 2003 S23 S28
113. G.J. Kelloff, R.A. Lubet, J.R. Fay Farnesyl protein transferase inhibitors as potential cancer chemopreventives Cancer Epidemiol Biomarkers Prev 6 1997 267 282
114. O.G. Scharovsky, V.R. Rozados, S.I. Gervasoni, P. Matar Inhibition of ras oncogene A novel approach to antineoplastic therapy J Biomed Sci 7 2000 292 298
115. C.J. Langer Role of targeted therapy in non-small cell lung cancer Hype or hope? Expert Rev Anticancer Ther 3 2003 443 455
116. F. Caponigro, M. Casale, J. Bryce Farnesyl transferase inhibitors in clinical development Expert Opin Investig Drugs 12 2003 943 954
117. J.L. Mulshine, F.R. Hirsch Lung cancer chemoprevention Moving from concept to a reality Lung Cancer 41 suppl 1 2003 S163 S174
118. R.S. Herbst, A.M. Maddox, M.L. Rothenberg Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors Results of a phase I trial J Clin Oncol 20 2002 3815 3825
119. A. Akhmedkhanov, P. Toniolo, A. Zeleniuch-Jacquotte Aspirin and lung cancer in women Br J Cancer 87 2002 49 53
120. M. Weis, C. Heeschen, A.J. Glassford Statins have biphasic effects on angiogenesis Circulation 105 2002 739 745
121. V. Costantini, P. Fuschiotti, A. Giampietri Effects of a stable prostacyclin analogue on platelet activity and on host immunocompetence in mice Prostaglandins 39 1990 581 599
122. R.L. Keith, Y.E. Miller, Y. Hoshikawa Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer Cancer Res 62 2002 734 740
123. C.I. Henschke, D.I. McCauley, D.F. Yankelevitz Early Lung Cancer Action Project Overall design and findings from baseline screening Lancet 354 1999 99 105